Genetic Engineering to Program Cells

Genetic engineering is a process that alters the genetic structure of an organism by removing or introducing DNA. This technique is being tested to program cells. Discover the latest research on genetic engineering to program cells here.

September 16, 2021
Open Access

Design and development of engineered receptors for cell and tissue engineering.

Current Opinion in Systems Biology
Shwan B Javdan, Tara L Deans
September 16, 2021
Open Access

Alveolar macrophage transcriptomic profiling in COPD shows major lipid metabolism changes.

ERJ Open Research
Wataru FujiiJoachim L Schultze
September 13, 2021
Preprint

Dynamical-systems theory of cellular reprogramming

ArXiv
Yuuki MatsushitaKunihiko Kaneko
September 15, 2021
Review

Emerging roles of Bromodomain protein 4 in regulation of stem cell identity.

Stem Cells
Anusree DeyHari Sharan Misra
September 14, 2021

Interleukin-11 signaling promotes cellular reprogramming and limits fibrotic scarring during tissue regeneration.

Science Advances
Srinivas AllankiSven Reischauer
September 14, 2021

Glutamine anaplerosis is required for amino acid biosynthesis in human meningiomas.

Neuro-oncology
Omkar B IjareKumar Pichumani
September 14, 2021

MUC1-C contributes to the maintenance of human embryonic stem cells and promotes somatic cell reprogramming.

Stem Cells and Development
Jeong-A ParkYounghee Lee
September 14, 2021
Review

Solute carrier transporters: emerging central players in tumour immunotherapy.

Trends in Cell Biology
Ruiqun Chen, Ligong Chen
September 10, 2021
Review
Open Access

Role of Copper on Mitochondrial Function and Metabolism.

Frontiers in Molecular Biosciences
Lina M RuizAlvaro A Elorza
September 10, 2021
Review

Sensory nerves: A driver of the vicious cycle in bone metastasis?

Journal of Bone Oncology
Toshiyuki YonedaKenji Hata
September 10, 2021
Review
Open Access

The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor.

Stem Cell Research & Therapy
Jared Becerril-RicoElizabeth Ortiz-Sánchez
September 10, 2021
Review
Open Access

MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype.

Cancers
Vincent TambayMarc Bilodeau
September 10, 2021
Review
Open Access

Advanced Technologies to Target Cardiac Cell Fate Plasticity for Heart Regeneration.

International Journal of Molecular Sciences
Gianluca TestaFabiana Passaro
September 10, 2021
Preprint
Open Access

Transcriptomic-based quantification of the epithelial-hybrid-mesenchymal spectrum across biological contexts

BioRxiv : the Preprint Server for Biology
S. MandalMohit Kumar Jolly
September 9, 2021

Chromosomal aberrations after induced pluripotent stem cells reprogramming.

Genetics and Molecular Biology
Isadora May VazPaulo Roberto Slud Brofman

Sign up to follow this feed and discover related papers.

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Artificial Cell Models

This feed focuses on biomimetrics, synthetic biology and bio- and tissue-engineering approaches used for modeling human diseases.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

© 2021 Meta ULC. All rights reserved
/feed-previews/genetic-engineering-to-program/f884d981-f108-49ca-8605-a4a2843df4d6